AnalystsRichard VosserRichard Vosser's Stock Forecasts
AnalystsRichard Vosser
Sectors:
Industries:
Analyst Ranking
Top 34%
#1865 out of 5511 analysts
Average Return
+27.51%
Win Rate
75%6 out of 8
Risk vs Reward
Poor
Good
Richard Vosser's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Morphosys AgMOR | +150.13% | $7.58 | $18.96 | 2023-12-05 - 2024-08-02 | Strong Buy |
Morphosys AgMOR | +134.97% | $7.72 | $18.14 | 2023-06-16 - 2024-06-14 | Strong Buy |
Novo Nordisk A SNVO | +35.95% | $57.94 | $78.77 | 2022-06-07 - 2023-06-07 | Strong Buy |
Lonza Group AgLZAGY | +13.22% | $64.73 | $73.29 | 2021-02-23 - 2021-07-12 | Strong Buy |
Novartis AgNVS | +6.49% | $130.17 | $138.62 | 2025-12-08 - 2026-09-15 | Strong Buy |
Richard Vosser Analyst Color
Get additional color on Richard Vosser's coverage of popular stocks
Richard Vosser's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novo Nordisk A SNVO | 3 | Hold | N/A | N/A | Downgrades | 7 months ago |
Molecular Partners AgMOLN | 3 | Hold | $3.75 | -10.71% | Maintains | 9 months ago |
Grifols SaGRFS | 1 | Hold | $10.00 | +35.87% | Maintains | 9 months ago |
SanofiSNY | 3 | Hold | N/A | N/A | Downgrades | 9 months ago |
Novartis AgNVS | 1 | Strong Buy | N/A | N/A | Upgrades | 9 months ago |
Morphosys AgMOR | 3 | Strong Buy | $8.50 | N/A | Maintains | 3 years ago |
Ucb SaUCBJY | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Lonza Group AgLZAGY | 1 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.